Actively Recruiting
Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
Led by Centre Hospitalier Sud Francilien · Updated on 2025-03-14
30
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
CONDITIONS
Official Title
Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Older than 18 years patient with type 1 or 2 diabetes
- Treated with multiple insulin injections
- Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before
- Dependent on a health professional for treatment management
- Subject informed of the study and not objecting to data collection
You will not qualify if you...
- Patient refusing study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France, 91106
Actively Recruiting
Research Team
M
Marie BOULY, APN
CONTACT
C
Caroline TOURTE
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here